|
Volumn 6, Issue 4, 2000, Pages 175-177
|
Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
ANTACID AGENT;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
BACTERIAL VACCINE;
CLARITHROMYCIN;
METRONIDAZOLE;
OMEPRAZOLE;
PROTON PUMP INHIBITOR;
UREASE;
ADULT;
ALPHA HEMOLYTIC STREPTOCOCCUS;
ANTIBIOTIC RESISTANCE;
BACTERIAL COUNT;
BACTEROIDES;
BIFIDOBACTERIUM;
CHRONIC GASTRITIS;
CLOSTRIDIUM;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG DOSAGE FORM;
ENTEROBACTERIACEAE;
ENTEROCOCCUS;
ERADICATION THERAPY;
ESCHERICHIA COLI;
HAEMOPHILUS;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
INTESTINE FLORA;
MINIMUM INHIBITORY CONCENTRATION;
MOUTH FLORA;
NONHUMAN;
NOTE;
PEPTIC ULCER;
PEPTOSTREPTOCOCCUS;
PRIORITY JOURNAL;
RANDOMIZATION;
STOMACH ANTRUM;
STOMACH CANCER;
STREPTOCOCCUS;
TREATMENT OUTCOME;
YEAST;
BACTERIA (MICROORGANISMS);
BACTEROIDES;
BIFIDOBACTERIUM;
CLOSTRIDIUM;
ENTEROBACTERIACEAE;
ENTEROCOCCUS;
ESCHERICHIA COLI;
HAEMOPHILUS;
HELICOBACTER;
HELICOBACTER PYLORI;
PEPTOSTREPTOCOCCUS;
STREPTOCOCCUS;
|
EID: 0034174715
PISSN: 1198743X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1469-0691.2000.00028.x Document Type: Note |
Times cited : (9)
|
References (14)
|